Equit, Linda T.

HRN: 27-58-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2025
CEFUROXIME 1.5GM (VIAL)
08/13/2025
08/14/2025
IVT
1.5g
Q8
S/p CS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: